Clinical Trials Browser

Breast Neoplasms

Breast Neoplasms

Neoplasms, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Colorectal Neoplasia

Healthy Adult Participants

Chemotherapy Effect

Pancreatic Neoplasms

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

Pancreatic Neoplasms, Peripheral Nervous System Diseases, Colorectal Neoplasms

Hodgkin Disease, Lymphoma, Non-Hodgkin

Advanced Solid Tumors

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Breast Neoplasms, Inflammation, Obesity

Esophageal Squamous Cell Carcinoma

Uterine Cervical Dysplasia

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms

Atrophy, Stomach Neoplasms

Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung

Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Prostate Cancer Patients

Breast Neoplasms

Advanced Solid Tumours

Advanced Solid Tumor

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms

Precancerous Gastric Lesions

Barrett Esophagus

Barrett Esophagus

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Solid Tumours

Lymphoma, Lymphoma, B-Cell, Marginal Zone

Zollinger-Ellison Syndrome, Gastrinoma

Pharmacokinetics of MDV3100

Carcinoma, Medullary

Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

Barrett Esophagus, Inflammation

Barrett Esophagus

Colorectal Neoplasms

Adult Solid Neoplasm

Head and Neck Neoplasms

Stomach Neoplasms

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

Clinical Trials

INAVO121

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

FASN

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

OU202005AJ

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

PEGASUS

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

KePreSt

ESO-Nanjing12

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

Drug Interaction Study of SAR302503 in Patients With Solid Tumor

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

INSPIRE

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer

Effect of a Proton Pump Inhibitor on the PK of Tepotinib

Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients

DDI

The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole

Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects

Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer

Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies

A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province

Argon Plasma Coagulation for Barrett's Esophagus

Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study

BAY73-4506 Probe Substrate Study

FORWARD

Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer

Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

Vandetanib

Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma

Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus

CC5

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors

A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer

Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma